OATP1B1 polymorphisms and torsemide pharmacokinetics and pharmacodynamics

被引：0
|
作者：
Vormfelde, S. V. [1 ]
Toliat, M. R. [2 ]
Schirmer, M. [1 ]
Meineke, I. [1 ]
Nuernberg, P. [2 ]
Brockmoeller, J. [1 ]
机构：
[1] Univ Gottingen, Dept Clin Pharmacol, Gottingen, Germany
[2] Univ Cologne, Cologne Ctr Genom, Cologne, Germany
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2007年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [21] Influence of genetic polymorphisms of uptake (OATP1B1) and efflux (BCRP/MRP2) transporters on the pharmacokinetics of rosuvastatin
    Tian, Lei
    Jiang, Juanjuan
    Liu, Hong
    Han, Lulu
    Huang, Yiling
    Li, Yishi
    CARDIOLOGY, 2013, 126 : 44 - 45
  • [22] Influence of SLCO1B1 (OATP1B1/OATP-C) gene polymorphisms on cholesterol responses to atorvastatin.
    Zineh, I
    Langaee, TY
    Wessel, TR
    Arant, CB
    Schofield, RS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P5 - P5
  • [23] Characteization of OATP1B1 and OATP1B3 inhibition by Nilotinib
    Sprowl, Jason A.
    Chen, Mingqing
    Gibson, Alice A.
    Pasquariello, Kyle Z.
    Sparreboom, Alex
    Hu, Shuiying
    FASEB JOURNAL, 2019, 33
  • [24] Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate
    Zhang, Yueping
    Panfen, Erika
    Fancher, Marcus
    Sinz, Michael
    Marathe, Punit
    Shen, Hong
    MOLECULAR PHARMACEUTICS, 2019, 16 (06) : 2342 - 2353
  • [25] Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)
    Niemi, M
    Kivistö, KT
    Hofmann, U
    Schwab, M
    Eichelbaum, M
    Fromm, MF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 602 - 604
  • [26] The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
    S P R Romaine
    K M Bailey
    A S Hall
    A J Balmforth
    The Pharmacogenomics Journal, 2010, 10 : 1 - 11
  • [27] The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
    Romaine, S. P. R.
    Bailey, K. M.
    Hall, A. S.
    Balmforth, A. J.
    PHARMACOGENOMICS JOURNAL, 2010, 10 (01): : 1 - 11
  • [28] Differential effects of OATP1B1 genetic polymorphism on the pharmacokinetics of pravastatin and pitavastatin.
    Deng, J.
    Song, I.
    Yeo, C.
    Shon, J.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S58 - S59
  • [29] Inter-individual pharmacokinetic variability of torsemide in healthy Korean males considering OATP1B1 and CYP2C9 genetic polymorphisms
    Lee, Y.
    Jeong, S.
    Jang, J.
    Cho, H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S105 - S105
  • [30] Effect of statins on OATP1B1 expression
    Duck, Zachary A.
    Wright, Stephen
    Wilkerson, Matt
    Li, Jibin
    Hidalgo, Ismael
    FASEB JOURNAL, 2013, 27
12345